Last update:

Gastroenterology news

GLP-1 agonist drugs show digestive side effects but may help fight infections

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to ...

New mouse model of virus-driven liver cancer may boost diagnosis and treatments

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease unfolds in people, from ...

Scientists target key protein duo driving colon, liver cancer

Cedars-Sinai Health Sciences University investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver cancer. Findings from the preclinical ...

How pancreatic tumors thwart an iron-driven demise

Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be harnessed for cancer therapy. Given that more than 95% of pancreatic ductal adenocarcinomas (PDACs) harbor ...

Plastic particles can increase intestinal inflammation

A research team led by the Medical University of Vienna and the University of Vienna has investigated a possible link between the rising number of people with chronic inflammatory bowel disease and the increasing exposure ...

What are prebiotics and probiotics?

The human gastrointestinal tract houses roughly 100 trillion microorganisms (good bacteria). These microorganisms make up what's called the gut microbiome.

How displacement reshapes refugees' gut health

Refugee health is often discussed in terms of crises such as disease outbreaks, malnutrition and psychological distress. But some of the most serious effects of displacement are harder to see. One example is how forced migration ...